Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial
Jordi Rodón(The University of Texas MD Anderson Cancer Center), Jean‐Charles Soria(Institut Gustave Roussy), Raanan Berger(Sheba Medical Center), Wilson H. Miller(Jewish General Hospital), Eitan Rubin(Ben-Gurion University of the Negev), Aleksandra Kugel(Ben-Gurion University of the Negev), Apostolia M. Tsimberidou(The University of Texas MD Anderson Cancer Center), Pierre Saintigny(Centre Léon Bérard), Aliza Ackerstein(Sheba Medical Center), Irene Braña(Vall d'Hebron Institute of Oncology), Yohann Loriot(Institut Gustave Roussy), Mohammad Afshar, Vincent A. Miller(Foundation Medicine (United States)), Fanny Wunder(Worldwide Universities Network), Catherine Bresson(Worldwide Universities Network), Jean-François Martini(Pfizer (United States)), Jacques Raynaud(Fondation ARC pour la Recherche sur le Cancer), John Mendelsohn(The University of Texas MD Anderson Cancer Center), Gerald Batist(Jewish General Hospital), Amir Onn(Sheba Medical Center), Josep Tabernero(Vall d'Hebron Institute of Oncology), Richard L. Schilsky(American Society of Clinical Oncology), Vladimir Lazar(Worldwide Universities Network), J. Jack Lee(The University of Texas MD Anderson Cancer Center), Razelle Kurzrock(University of California San Diego)
Cited by 594Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis